Navigation Links
Mesenchymal Stem Cells Have New Cell Culture Environment

BILLERICA, Mass., Feb. 8, 2012 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the availability of the new BD Mosaic™ Mesenchymal Stem Cell Serum-Free (hMSC SF), a complete cell culture environment for human mesenchymal stem cells (hMSCs) derived from bone marrow.

The BD Mosaic hMSC cell culture environment is designed to provide cell expansion in a shorter culture time—about half the time of traditional serum-based media. Starting with a low minimum seeding density (3,000–4,000 cells / cm2), BD Mosaic can achieve two or more doublings per passage without re-feeding between passages. Such performance can help deliver experimental results faster and lower total cost, as well as reduce handling and potential contamination.

"An intrinsic property of mesenchymal stem cells is their ability to differentiate into various somatic tissues," said Gregory Crescenzi, Marketing Manager, BD Biosciences. "Mesenchymal Stem Cells expand using the BD Mosaic hMSC SF cell culture environment and reliably retain their multipotency, even after many passages."

The performance provided by the BD Mosaic hMSC cell culture environment, coupled with its lot-to-lot consistency, can offer reliable results with speed and confidence. The serum-free composition lessens variability and potential contamination events to further streamline the cell culture process and reduce risk.

The BD Mosaic hMSC cell culture environment includes the expansion medium, a media supplement and an advanced cell culture surface coating. It is the first product in BD's line of next-generation environments for the expansion of stem cells.

About BD
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit

Jamie Yacco
Public Relations
(201) 847-4796

SOURCE BD (Becton, Dickinson and Company)
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells
2. ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Mesenchymal Cells
3. STEMCELL Technologies Introduces a New Animal Component-Free, Serum-Free Medium for Culturing Human Mesenchymal Stem Cells
4. Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials
5. Limbs saved by menstrual blood stem cells
6. UC Riverside researcher develops novel method to grow human embryonic stem cells
7. Stem cells stand up for themselves
8. Carnegie Mellon MRI technology that noninvasively locates, quantifies specific cells in the body
9. Researchers decode viral process that prepares cells for HIV infection
10. MaxCyte and Medinet to Present at the 10th International Symposium on Dendritic Cells in Kobe, Japan
11. Using living cells as nanotechnology factories
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... published their findings on what they believe could be a new and helpful ... the new research. Click here to read it now. , Biomarkers ...
(Date:6/27/2016)... Ginkgo Bioworks , a leading organism design company ... as one of the World Economic Forum,s Technology ... companies. Ginkgo Bioworks is engineering biology to manufacture ... the nutrition, health and consumer goods sectors. The ... Fortune 500 companies to design microbes for their ...
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
Breaking Biology Technology:
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
Breaking Biology News(10 mins):